» Articles » PMID: 37445874

Mitochondria-Targeting 1,5-Diazacyclooctane-Spacered Triterpene Rhodamine Conjugates Exhibit Cytotoxicity at Sub-Nanomolar Concentration Against Breast Cancer Cells

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Jul 14
PMID 37445874
Authors
Affiliations
Soon will be listed here.
Abstract

1,5-Diazacyclooctane was prepared by a simple synthetic sequence and coupled to pentacyclic triterpenoic acids oleanolic acid, ursolic acid, betulinic acid, platanic acid, and asiatic acid; these amides were activated with oxalyl chloride and reacted with rhodamine B or rhodamine 101 to yield conjugates. The conjugates were screened in SRB assays with various human breast cancer cell lines (MDA-MB-231, HS578T, MCF-7, and T47D) and found to exert cytotoxic activity even at a low concentration. Therefore, for an asiatic acid rhodamine 101 conjugate (28), an IC = 0.60 nM was determined and found to induce apoptosis in MDA-MB-231 and HS578T cells. Extra experiments showed the compound to act as a mitocan and to induce inhibition of proliferation or growth arrest in MDA-MB-231 cells at lower doses followed by an induction of apoptosis at higher doses. Furthermore, differential responses to proliferation inhibition and apoptosis induction may explain differential sensitivity of mammary cell lines to compound 28.

Citing Articles

Integration of Transcriptomics and Metabolomics Reveals the Antitumor Mechanism of Protopanaxadiol Triphenylphosphate Derivative in Non-Small-Cell Lung Cancer.

Han L, Bian X, Ma X, Ren T, Li Y, Huang L Molecules. 2024; 29(17).

PMID: 39275122 PMC: 11396780. DOI: 10.3390/molecules29174275.


Synthesis of Rhodamine-Conjugated Lupane Type Triterpenes of Enhanced Cytotoxicity.

Denner T, Heise N, Hoenke S, Csuk R Molecules. 2024; 29(10).

PMID: 38792206 PMC: 11123818. DOI: 10.3390/molecules29102346.


Can Asiatic Acid from Be a Potential Remedy in Cancer Therapy?-A Review.

Wicinski M, Fajkiel-Madajczyk A, Kurant Z, Gajewska S, Kurant D, Kurant M Cancers (Basel). 2024; 16(7).

PMID: 38610995 PMC: 11011005. DOI: 10.3390/cancers16071317.


F16 Hybrids Derived from Steviol or Isosteviol Are Accumulated in the Mitochondria of Tumor Cells and Overcome Drug Resistance.

Heise N, Heisig J, Meier K, Csuk R, Mueller T Molecules. 2024; 29(2).

PMID: 38257294 PMC: 10821019. DOI: 10.3390/molecules29020381.


Mitochondria-Targeted Lipid Nanoparticles Loaded with Rotenone as a New Approach for the Treatment of Oncological Diseases.

Vasileva L, Gaynanova G, Kuznetsova D, Valeeva F, Lyubina A, Amerhanova S Molecules. 2023; 28(20).

PMID: 37894708 PMC: 10609561. DOI: 10.3390/molecules28207229.


References
1.
Garrido-Castro A, Lin N, Polyak K . Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment. Cancer Discov. 2019; 9(2):176-198. PMC: 6387871. DOI: 10.1158/2159-8290.CD-18-1177. View

2.
Serbian I, Hoenke S, Csuk R . Synthesis of some steroidal mitocans of nanomolar cytotoxicity acting by apoptosis. Eur J Med Chem. 2020; 199:112425. DOI: 10.1016/j.ejmech.2020.112425. View

3.
Ha K, Monbaliu J, Williams B, Pillai G, Ocampo C, Zeller M . A convenient synthesis of difficult medium-sized cyclic peptides by Staudinger mediated ring-closure. Org Biomol Chem. 2012; 10(40):8055-8. DOI: 10.1039/c2ob25996f. View

4.
Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

5.
Shi J, Wang H, Wang Y, Peng Y, Huang X, Zhang Y . Mitochondrion-targeting and in situ photocontrolled protein delivery via photocages. J Photochem Photobiol B. 2022; 238:112624. DOI: 10.1016/j.jphotobiol.2022.112624. View